|
Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference. The trial was sponsored by the University of Arkansas for Medical Sciences. William “Bill” Culp, MD, the principal investigator on the trial, said, “Such strong safety and promising efficacy results meet our highest hopes for this small trial. Expanded trials are fully warranted.”Continue reading
University of Arizona researchers will compete in a “Shark Tank”-style competition, demonstrate their medical technology and more during Research Day, a first-of-its-kind event coordinated by the UA College of Medicine – TucsonContinue reading
Local high school students will practice their health-care skills, such as CPR and ultrasound imaging, during “A Pathway to Success,” an interactive health-care career fair spearheaded by residents at the University of Arizona College of Medicine – Tucson South Campus.Continue reading
– Company is Focused on Slowing Brain Tumor Progression, Improving Quality of Life for Patients and Caregivers
– Seasoned Life Science Industry Executives Prattipati Laxminarain and Mara Aspinall Join Board of DirectorsContinue reading
UAVenture Capital has launched a second venture capital fund designed specifically to help finance the commercialization of emerging and disruptive technologies formulated by UA researchers, faculty and students.Continue reading
Regenerative Medicine Patch Advances Wound RepairContinue reading
Cancer remains a leading cause of death globally and is the focus of exhaustive and varied medical research. Many of Arizona State University’s Biodesign Institute researchers are working to establish alternative therapies that sidestep the harmful effects of chemotherapy and radiation while improving the success rate for the more difficult-to-treat cancers.Continue reading
The University of Arizona Cancer Center collaborated with researchers at the Medical University of South Carolina to uncover better ways to harness the immune system to fight cancer.Continue reading